MONITORING SKELETAL CANCER METASTASES WITH THE BONE ISOENZYME OF TISSUE UNSPECIFIC ALKALINE-PHOSPHATASE

The efficacy of bone alkaline phosphatase (ALP) isoenzyme measurement using lectin precipitation in confirming metastatic bone lesions was c ompared with total ALP and osteocalcin assay in serum. Sixty-five pati ents with cancer and metastases to bone (n = 44), liver (n = 15) or ly mph nodes (n = 6) as well as 33 healthy adutls were studied. Assay of bone ALP is as sensitive but more specific than assay of total ALP in the identification of bone metastases. On the other hand, bone ALP did not correlate with osteocalcin, as is the case in other bone diseases . In the serial monitoring of nine patients with skeletal metastases, bone ALP correlated well with the presence of pain and the progression or regression of metastatic spread.